Description
A mixture of the antibiotics sulfamethoxazole and trimethoprim; bactericidal against 12 patient-derived community-acquired MRSA strains at 0.05 mg/L; prevents lung and spleen bacterial colonization in a mouse model of inhaled B. mallei infection at 240 mg/kg; resolves cutaneous tail lesions in a mouse model of S. xylosus infection
Formal name: 5-[(3,4,5-trimethoxyphenyl)methyl]-2,4-pyrimidinediamine mixture with 4-amino-N-(5-methyl-3-isoxazolyl)-benzenesulfonamide
Synonyms: TMP-SMX|Trimethoprim-Sulfamethoxazole
Molecular weight: 543.6
CAS: 8064-90-2
Purity: ≥98%
Formulation: A solid